Literature DB >> 3439801

Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius.

M S Lantz1, T Ray, S Krishnasami, D E Pearson.   

Abstract

Previous studies from our laboratory have shown that a strain of Bacteroides intermedius, VPI 8944, an organism isolated originally from a patient with acute necrotizing ulcerative gingivitis, binds human fibrinogen rapidly, reversibly, specifically, saturably, and with high affinity (M.S. Lantz, L.M. Switalski, K.S. Kornman, and M. Höök, J. Bacteriol. 163:623-628, 1985). We examined the effect of growth in subinhibitory levels (sub-MICs) of tetracycline on fibrinogen binding by these bacteria and found concentration-dependent inhibition of fibrinogen binding by bacteria grown in the presence of tetracycline over the range of tetracycline concentrations from 1/64 to 1/8 the MIC. Analysis of the binding data suggests that bacteria grown in the presence of sub-MICs of tetracycline bind fewer fibrinogen molecules per cell than do bacteria grown in the absence of the drug. If fibrinogen-mediated adherence is important in the establishment B. intermedius in periodontal lesions and lesions of acute necrotizing ulcerative gingivitis, then tetracycline may be effective in disrupting establishment of these organisms at concentrations well below those required to achieve a bacteriostatic effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439801      PMCID: PMC175827          DOI: 10.1128/AAC.31.12.1915

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Interactions of Bacteroides gingivalis with fibrinogen.

Authors:  M S Lantz; R W Rowland; L M Switalski; M Höök
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Number of receptor sites from Scatchard and Klotz graphs: a constructive critique.

Authors:  P J Munson; D Rodbard
Journal:  Science       Date:  1983-05-27       Impact factor: 47.728

Review 3.  Antibiotics in the treatment of human periodontal diseases.

Authors:  R J Genco
Journal:  J Periodontol       Date:  1981-09       Impact factor: 6.993

4.  The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis.

Authors:  K S Kornman; E H Karl
Journal:  J Periodontol       Date:  1982-10       Impact factor: 6.993

5.  Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline.

Authors:  J Slots; B G Rosling
Journal:  J Clin Periodontol       Date:  1983-09       Impact factor: 8.728

6.  Influence of sublethal antibiotic concentrations on bacterial adherence to saliva-treated hydroxyapatite.

Authors:  W J Peros; R J Gibbons
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Bacteriology of human experimental gingivitis: effect of plaque age.

Authors:  S A Syed; W J Loesche
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria.

Authors:  C B Walker; J M Gordon; S J McQuilkin; T A Niebloom; S S Socransky
Journal:  J Periodontol       Date:  1981-10       Impact factor: 6.993

9.  Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses.

Authors:  J M Gordon; C B Walker; J C Murphy; J M Goodson; S S Socransky
Journal:  J Periodontol       Date:  1981-10       Impact factor: 6.993

10.  An evaluation of minocycline in patients with periodontal disease.

Authors:  S G Ciancio; M L Mather; J A McMullen
Journal:  J Periodontol       Date:  1980-09       Impact factor: 6.993

View more
  4 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

2.  What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?

Authors:  L Dorey; S Hobson; P Lees
Journal:  J Vet Pharmacol Ther       Date:  2017-01-18       Impact factor: 1.786

3.  Systemic antibiotic therapy in periodontics.

Authors:  Anoop Kapoor; Ranjan Malhotra; Vishakha Grover; Deepak Grover
Journal:  Dent Res J (Isfahan)       Date:  2012-09

4.  Systemic anti-microbial agents used in periodontal therapy.

Authors:  Vishakha Patil; Rohini Mali; Amita Mali
Journal:  J Indian Soc Periodontol       Date:  2013-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.